A teclpique for quantitative determination of cephalothin and desacetylcephalothin in serum using a method based on high-pressure liquid chromatography is described. Both compounds were quantitatively extracted from serum by using dimethylformamide. After separation of the drugs by reverse-phase chromatography and detection by ultraviolet light absorption at 254 nm, serum concentrations of cephalothin and desacetylcephalothin as low as 1.0 jig/ml were measured.
Cephalothin is a semisynthetic derivative of cephalosporin C that became available for clinical trials in the United States in 1962. Since its introduction, it has been widely used with great success in infectionrs involving a variety of grampositive and gram-negative bacteria (10, 15, 20) . Despite cephalothin's great popularity and proven efficacy, caution should be exercised in its administrato , especially with large doses. Although infrequently reported, renal failure can occur with large doses of cephalothin or in the presence of previous azotemia (3, 14, 16, 18, 19) . Therefore, rapid and accurate monitoring of seru.m levels of this antibiotic becomes essential in these clinical settings. Moreover, a readily available method to determine serum concentrations of cephalothin may be important to properly assess appropriate therapeutic doses.
Recently we have successfully applied highpressure liquid chromatography (HPLC) to the quantitation of antibiotics in serum and cerebrospinal fluid (12, 13) . This technique has advantages over standard microbiological assays with regard to accuracy, specificity, and rapidity. Predicated on these earlier results, the technique t Present address: Department of Infectious Diseases, University Hospital of Lund, 22185 Lund, Sweden. of HPLC was applied to the determination of cephalothin concentrations in serum. A one-step quantitative extraction of the drug from serum with dimethylformamide (DMF), followed by separation using reverse-phase HPLC, and, finally, detection of cephalothin in the eluent with ultraviolet spectrophotometry resulted in a rapid assay which also had a high degree of accuracy, sensitivity, and specificity. MATERIALS In vitro serum samples. Aqueous solutions of sodium cephalothin (USP Reference Standard) were prepared and stored at -70°C for no longer than 1 month. Desacetylcephalothin as the free acid (kindly donated by Robert Furman, Lilly Research Laboratories, Indianapolis, Ind.) was dissolved in DMF (2 mg/ml) and further diluted with water. A quantity of 0.1 ml of each of the standards was added to 0.8 ml of dog or human sera and incubated at ambient temperature for at least 20 min. Blanks were prepared in the same manner except for omission of the two drugs. Also, controls in which water was substituted for serum were employed.
In vivo dog samples. (6) was employed. A quantity of 1 ml of serum was mixed with 1.0 ml of DMF. The mixture was incubated at 500C for 10 min and centrifuged at 2,000 x g for 10 min at ambient temperature, and 0.8 ml of the supernatant was mixed with 0.8 ml of water. This mixture was then passed through 0.5-,um filters (Solvinert, Millipore Corp.).
(ii) Separation, detection, and quantitation. A volume of 100 pl of the filtered solution was injected into the liquid chromatograph. Cephalothin and its desacetyl metabolite were eluted with methanol-acetic acid as mobile phase at a flow rate of 2.5 ml/min. The eluent was monitored at 254 nm at an attenuation of 0.01 absorbance unit full scale. Recorder chart speed was 0.5 cm/min. Quantitation was based on integration of peak areas using an HP3380A integrator previously calibrated with known concentrations of cephalothin and desacetylcephalothin.
(ill) Critical steps. Special attention was given to several of the steps in the procedure.
(1) The serum sample and DMF were left for 10 min to ensure maximum protein precipitation and quantitative extraction of cephalothin and its desacetyl metabolite.
(2) All solvents and extracts were filtered through 0.5-um filters before chromatography to prevent particulate matter from obstructing filters in the chromatograph.
(3) Deaeration of the mobile phase was essential because air bubbles caused base line drift and excessive noise in the detector.
RESULTS
Choice of detection wavelength. The ultraviolet absorption maximum for cephalothin was found at 236 nm. The flow detector used with the chromatograph operated with fixed wavelengths, and 254 nm was the available wavelength closest to the absorption maximum.
At this wavelength, cephalothin exhibited an absorption that was approximately 2/3 of the maximal absorption at 236 mm.
Separation of cephalothin and desacetylcephalothin by liquid chromatography.
With the chromatographic system described, cephalothin and desacetylcephalothin had retention times of 9.99 and 4.44 min, respectively. Both were well separated from each other and other detectable substances in serum extracts (Fig. 1) . Extracts of serum not containing these antibiotics showed no detectable absorption at these retention times when chromatographed (Fig. 1) . After elution of cephalothin, other ultraviolet light-absorbing material was observed for approximately 30 min. To elute these latter substances more rapidly, the methanol in the mobile phase was increased to 100%, and the column was washed for 5 min. Finally, the original mixture of methanol-acetic acid was allowed to equilibrate with the column until the base line became stable. The system was then ready for determination of the next sample.
Recovery. A standard curve was obtained by HPLC using aqueous solutions of cephalothin (Fig. 2 ). An alnost identical relationship was found when aqueous solutions of cephalothin were substituted for serum (Fig. 2 ). This linear relationship was found to extend from concentrations of 1 to 100 ,ug/ml. Similar findings were noted for desacetylcephalothin.
Sensitivity. The base line fluctuation in the detector allowed a slope sensitivity setting of 1.0 mV/min on the integrator. This permitted detection of 25 ng of cephalothin or desacetylcephalothin, corresponding to serum concentrations of 1.0 ,ug/ml. For concentrations of cephalothin below 2.0 ,ug/ml, a higher concentration of methanol (45%) in the mobile phase, resulting in a shorter retention time and a sharper peak, was necessary for increased accuracy. For subsequent determinations, the column should be cleaned and equilibrated with the original methanol-acetic acid mixture as described above.
Precision Disappearance from the circulation. Figure 3 illustrates a time curve for the disappearance of cephalothin from the circulation in a human after a single intravenous dose of 1.0 g of cephalothin.
Values from the chemical analysis of cephalothin and desacetylcephalothin along with the corresponding microbiological assay are plotted on the same graph. Approximately 85% of cephalothin was removed from serum by 30 min. The drug could not be detected at 2 h and thereafter with either assay. This has been noted by several investigators previously (7, 8, 17) . Desacetylcephalothin was detected by the chemical assay at low concentrations immediately after completion of cephalothin infusion, but could not be measured after 0.5 h. Similar data were found with the second human volunteer.
In Fig. 4 , the disappearance curve of cephalothin after an intravenous dose in a single dog is depicted. Cephalothin, determined by the chemical assay, rapidly disappeared from serum, as in humans. However, in contrast to humans, the concentrations of desacetylcephalothin in serum exceeded that of the parent compound and remained in the circulation for a longer period of time (up to 6 h). In the other two dogs, similar disappearance curves for cephalothin and desacetylcephalothin were found. Correlation with microbiological assay. The miniimum inhibitory concentrations of cephalothin and desacetylcephalothin to the test organism were 0.05 and 0.20 ug/ml, respectively. These findings correlate well with findings of other investigators in that the desacetyl metabolite of cephalothin has only 20 to 25% of the biological activity of its parent compound (1, 7) .
Serum samples from the two human volunteers were assayed in duplicate by the microbiological as well as the chemical method. When the bioassay values were compared with the corresponding cephalothin concentrations determined byt chromatography, the correlation coefficient was 0.96 (Fig. 5) . Since the microbiological assay in part reflects activity of the desacetyl metabolite of cephalothin, the correlation coefficient was also calculated by comparing microbial assay values with the sum of serum concentrations of cephalothin and desacetylcephalothin determined by the chemical assay (Fig. 6) . However, the correlation remained basically unchanged.
Upon comparison of values obtained by bioassay and chemical assay in the dog experiments, the correlation coefficient was less. If the microbial assay values were compared with those of cephalothin alone, desacetylcephalothin alone, or the sum of cephalothin plus desacetylcephalothin (all determined by the chemical assay), the correlation coefficients were 0.79, 0.84, and 0.80, respectively. This lower correlation coefficient in dogs may be due to the higher concentrations of desacetylcephalothin in the sera of Recently, the HPLC technique has been successfully implemented for rapid, accurate, and specific measurements of tetracycline (13) and amphotericin B (12) in serum and cerebrospinal fluid. The complete methodology involved simple extraction of antibiotics from the samples, followed by separation by HPLC and, finally, detection of the compounds by ultraviolet spectrometry.
The application of HPLC to quantitation of cephalothin has been previously reported (2, 4 With the technique of HPLC, the desacetyl metabolite of cephalothin is also accurately measured, which is not possible by microbiological assays. Since its biological activity is known to be much less than that of the parent compound, it may be important to assess quantitatively its distribution in various body fluids to better understand the pharmacokinetics and efficacy of cephalothin therapy. For example, the high rate of failure of cephalothin in the treatment of bacterial meningitis (5) has been attributed not only to its variable penetration into the cerebrospinal fluid but also to the possible presence of the less active metabolite, desacetylcephalothin in the cerebrospinal fluid. These problems can now be investigated by using techniques such as the one described in this paper.
Approximately 75% of circulating cephalothin is bound to serum proteins (11) . Therefore, complete disassociation from proteins is essential for determination of total serum concentrations. The chemical procedure reported here is a chemical assay in which cephalothin and its desacetyl metabolite were quantitatively recovered from serum. The lack of interference from a variety of other drugs including antibiotics is extremely useful, since many patients may receive combination antimicrobial therapy (9) . The data presented demonstrates that this technique is also precise, reproducible, and well correlated to the microbiological assay. Its sensitivity of 1 tg/ml is more than adequate for routine use. Additionally, the methodology described here is extremely rapid. The entire procedure can be performed in 30 min for a single serum sample.
Thus, this chemical assay appears feasible for routine clinical use and moreover may be implemented for investigation of the pharmacokinetics of cephalothin and desacetylcephalothin.
